T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
National Presto Industries
NPK
$987M
| $514K | ﹤0.01% |
5,054
+105
| +2% | +$10.8K |
|
|
VRS
2377
DELISTED
Verso Corporation
VRS
| $514K | ﹤0.01% |
29,015
+391
| +1% | +$6.45K |
|
2378
Arcus Biosciences
RCUS
$3.67B
| $511K | ﹤0.01% |
18,623
-2,612
| -12% | -$74.6K |
|
|
RDUS
2379
DELISTED
Radius Recycling
RDUS
| $508K | ﹤0.01% |
10,350
-2,005
| -16% | -$99.7K |
|
2380
Fidelity MSCI Information Technology Index ETF
FTEC
$21.6B
| $507K | ﹤0.01% |
4,302
| – | – |
|
|
AGR
2381
DELISTED
Avangrid, Inc.
AGR
| $504K | ﹤0.01% |
9,797
-2,668
| -21% | -$139K |
|
2382
Arrow Financial
AROW
$723M
| $502K | ﹤0.01% |
15,252
+2,865
| +23% | +$94K |
|
2383
Cushman & Wakefield Ltd
CWK
$3.37B
| $499K | ﹤0.01% |
28,568
+2,406
| +9% | +$42.8K |
|
2384
American Well
AMWL
$220M
| $498K | ﹤0.01% |
1,981
+814
| +70% | +$235K |
|
2385
PBF Energy
PBF
$8.81B
| $496K | ﹤0.01% |
32,394
+1,492
| +5% | +$23K |
|
|
SPTN
2386
DELISTED
SpartanNash
SPTN
| $494K | ﹤0.01% |
25,589
-5,929
| -19% | -$118K |
|
|
AAT
2387
American Assets Trust
AAT
$1.41B
| $493K | ﹤0.01% |
13,223
+784
| +6% | +$27.9K |
|
|
VCRA
2388
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $493K | ﹤0.01% |
12,377
+808
| +7% | +$29.5K |
|
2389
AudioCodes
AUDC
$253M
| $492K | ﹤0.01% |
14,869
+967
| +7% | +$30.9K |
|
2390
Ocular Therapeutix
OCUL
$2.22B
| $491K | ﹤0.01% |
34,660
+1,759
| +5% | +$26.7K |
|
2391
Haverty Furniture Companies
HVT
$450M
| $490K | ﹤0.01% |
11,462
-2,647
| -19% | -$116K |
|
2392
PJT Partners
PJT
$4.57B
| $490K | ﹤0.01% |
6,861
+492
| +8% | +$35.1K |
|
|
SPPI
2393
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $488K | ﹤0.01% |
130,104
+4,412
| +4% | +$15.3K |
|
2394
Omeros
OMER
$1.26B
| $485K | ﹤0.01% |
32,655
-1,391
| -4% | -$23.3K |
|
2395
Anavex Life Sciences
AVXL
$303M
| $483K | ﹤0.01% |
21,141
-501
| -2% | -$7.42K |
|
2396
Revolve Group
RVLV
$1.72B
| $483K | ﹤0.01% |
+7,012
| New | +$377K |
|
|
RIDE
2397
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $483K | ﹤0.01% |
2,910
+630
| +28% | +$96.8K |
|
2398
The Greenbrier Companies
GBX
$1.42B
| $481K | ﹤0.01% |
11,040
+565
| +5% | +$26.1K |
|
2399
Liberty Latin America Class A
LILA
$1.67B
| $479K | ﹤0.01% |
50,884
-6,618
| -12% | -$62.8K |
|
|
MRC
2400
DELISTED
MRC Global
MRC
| $479K | ﹤0.01% |
51,008
-10,104
| -17% | -$103K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.